JOURNAL ARTICLE
FEATURED

The use of live cell imaging and automated image analysis to assist with determining optimal parameters for angiogenic assay in vitro

2019 Frontiers in Cell and Developmental Biology 7:14 pages Frontiers Media
Co-authors: Huuskes BM, DeBuque RJ, Kerr PG...2 more
DOI: 10.3389/fcell.2019.00045

Testing angiogenic potential and function of cells in culture is important for the understanding of the mechanisms that can modulate angiogenesis, especially when discovering novel anti- or pro-angiogenic therapeutics. Commonly used angiogenic assays include tube formation, proliferation, migration, and wound healing, and although well-characterized, it is important that methodology is standardized and reproducible...

1515 total citations on Dimensions.
FEATURED

Endothelial Progenitor Cells and Vascular Health in Dialysis Patients

2018 Kidney International Reports 3(1):205-211 (7 pages) Elsevier
Co-authors: Huuskes BM, DeBuque RJ, Polkinghorne KR...3 more
DOI: 10.1016/j.ekir.2017.09.004
33 total citations on Dimensions.
FEATURED

Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathy

2015 The FASEB Journal 29(2):540-553 (14 pages) Federation of American Societies for Experimental Biology
Co-authors: Huuskes BM, Wise AF, Cox AJ...5 more
DOI: 10.1096/fj.14-254789

Chronic kidney disease (CKD) results from the development of fibrosis, ultimately leading to end-stage renal disease (ESRD). Although human bone marrow-derived mesenchymal stem cells (MSCs) can accelerate renal repair following acute injury, the establishment of fibrosis during CKD may affect their potential to influence regeneration capacity...

66 total citations on Dimensions. Article has an altmetric score of 37

Reflections on our role as patient representatives for CKJ

1 Jul 2025 CKJ: Clinical Kidney Journal 18(7):1 page Oxford University Press
Co-authors: Iwakura T, Huuskes BM
DOI: 10.1093/ckj/sfaf202
Article has an altmetric score of 1

Core Outcome Measure for Life Participation in Patients with Chronic Kidney Disease: Standardized Outcomes in Nephrology Workshops Report

26 Jun 2025 Clinical Journal of the American Society of Nephrology 20(8):1041-1050 Wolters Kluwer
Co-authors: Hughes A, Gonzalez AM, Amir N...38 more
DOI: 10.2215/cjn.0000000724

Key Points: Patients, caregivers, and health professionals support the use of standardised outcomes in nephrology - life participation as the core outcome measure for life participation in patients with CKD. Further work is needed to pilot and validate the standardised outcomes in nephrology...

Ten tips to improve adherence to immunosuppressive medication after kidney transplantation

1 Jun 2025 Clinical Kidney Journal 18(6):1-11 (11 pages) Oxford University Press (OUP)
Co-authors: Mahmood K, Allen J, Varley R...3 more
DOI: 10.1093/ckj/sfaf164

Non-adherence is an issue in all chronic health conditions and the World Health Organization estimates that up to 50% of patients do not take all of their medications. The situation in kidney transplant patients is probably better, as these patients are preselected for good adherence and proactive behaviour...

1 citation on Dimensions. Article has an altmetric score of 6
CONFERENCE PAPER

Evaluation of an asynchronous "Kickstart" program for students entering second year anatomy

1 Feb 2025 21st Annual Meeting of the Australian and New Zealand Association of Clinical Anatomists (ANZACA)
Anatomical Sciences Education 18(2):210-211 (211 pages) Wiley-Blackwell
Co-authors: Huuskes B, McGowan H, McDonald A...1 more
DOI: 10.1002/ase.2554

EXPLORING THE IMPACT OF INTERLEUKIN-37 ON PRO-INFLAMMATORY PATHWAYS IN TWO MODELS OF KIDNEY DISEASE

1 Aug 2024 NEPHROLOGY 29:25 (1 page) WILEY
Co-authors: Gasperoni J, Vinh A, Saini N...2 more

HOSPITAL ADMISSIONS DURING THE FIRST 10-YEARS OF LIFE IN CHILDREN BORN TO KIDNEY TRANSPLANTED MOTHERS

1 Aug 2024 NEPHROLOGY 29:46 (1 page) WILEY
Co-authors: Hewawasam E, Davies C, Huuskes B...3 more